Education

• Postdoctoral Training Pharmacology 1994-1995, University of Pittsburgh, Pennsylvania.
• PhD 1994, Department of Biological Sciences, Purdue University,
  West Lafayette, Indiana.
• BS Biology 1989, Peking University, Beijing, China.

---

Areas of Interest

• Development of novel receptor-targeted drug delivery systems and therapeutic strategies.
  
  
• Liposomal formulations and nanoparticle drug carriers for anticancer agents.
  
  
• Gene and oligonucleotide delivery, neutron capture therapy, cancer imaging, cancer immunotherapy.

---

Courses Taught

Undergraduate/Professional Courses

1998 – 1999 Pharmacy 403 (3 credit), Introduction to Pharmaceutics; required for BS in Pharmacy (professional program).

1999 – present Pharmacy 420 (4 credit), Biopharmaceutics and Physical Pharmacy; required for BS in Pharm. Sci. (BSPS) undergraduate program

Served as Faculty Advisor for numerous BSPS students

Graduate Level Courses

2000 – present Pharmacy 807 (3 credit, every other year), Advanced Drug Delivery Systems, required for PhD in Pharmaceutics

2004, Pharmacy 623 (5 credits) Drug Delivery III, 5 credit, member of the instructional team, required for the Pharm D curriculum.

---

Professional Experience

2004 - present: Member (Executive Committee) of the NSF Nanoscience and Engineering Center (NSEC) ----- Center for Affordable Nanoengineering of Polymer Biomedical Devices (CANPBD)

2002 - present: Associate Professor, The Ohio State University, College of Pharmacy, Division of Pharmaceutics, Columbus, OH.

1998 - present: Member of the Experimental Therapeutics Program, The Ohio State University Comprehensive Cancer Center (OSUCCC).

1997 - 2002: Assistant Professor of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, Ohio.

1996-1997: Visiting Scholar, Department of Chemistry, Purdue University, West Lafayette, Indiana. Research area: Design and evaluation of novel targeted radionuclide tumor imaging and immunotherapy agents.

1996 -1997: Vice President of Research & Development , Endocyte, Inc., West Lafayette, Indiana. Responsibilities include directing and coordinating company-sponsored research & development projects, preparation and submission of NIH SBIR grant applications, and the preparation and submission of an Investigational New Drug (IND) application for a Phase I/II clinical study on 111In-DTPA-folate, a novel targeted radiopharmceutical for imaging of ovarian cancer.

1995 - 1996: Senior Scientist , Gene Delivery Department, Director, Dr. Alain Rolland, GeneMedicine, Inc., The Woodlands, Texas. Research area: Lipid and peptide-based gene delivery systems.

1994-1995: Postdoctoral Research Associate , under Prof. Leaf Huang (Joseph Koslow Professor of Pharmaceutical Sciences) in the Department of Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Research area: non-viral delivery systems of gene therapy.

---